drugset / Trial / NCT07537231

A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants

NCT07537231 ↗

Phase 1 Active not recruiting 6 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelHealth-services research

Summary

This is a single-center, non-randomized, open-label, single-dose clinical PK study in healthy postmenopausal female participants.

Timeline

Start
2026-04-09
Primary completion
2026-04-18
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject GS1-144 Unknown 30 mg Oral

Indications

No indication recorded.